Al-Ahmadi, Wajdan
2019.
The role of the ERK1: STAT1 serine 727 phosphorylation axis on key atherosclerosis associated cellular processes and the anti-atherogenic actions of hydroxytyrosol.
PhD Thesis,
Cardiff University.
Item availability restricted. |
|
|
Gallagher, Hayley, Moss, J.W.E, Williams, J, Davies, T.S., Al-Ahmadi, Wajdan, O'Morain, Victoria and Ramji, Dipak ORCID: https://orcid.org/0000-0002-6419-5578
2017.
Nutraceuticals in the prevention and treatment of Atherosclerosis.
Cardiology
137
(S1)
, p. 264.
10.1159/000477751
|
|
|
Davies, T.S., Gallagher, Hayley, Moss, J. W. E., Jaffar, F.B., Al-Ahmadi, Wajdan, Harris, Ffion and Ramji, Dipak ORCID: https://orcid.org/0000-0002-6419-5578
2016.
The action of Nutraceuticals on key macrophage processes associated with Atherosclerosis.
Cardiology
134
(S1)
, p. 314.
10.1159/000447505
|
|
|
Ramji, Dipak ORCID: https://orcid.org/0000-0002-6419-5578, Davies, Thomas, Gallagher, Hayley, Moss, Joe ORCID: https://orcid.org/0000-0002-1866-9752, Faizah, Jaffar and Al-Ahmadi, Wajdan
2016.
Cytkines in atherosclerosis: molecular mechanisms underlying their actions and promising therapeutic targets [Abstract].
Journal of Clinical and Experimental Cardiology
7
(6)
, p. 52.
|
|
|
Ramji, Dipak ORCID: https://orcid.org/0000-0002-6419-5578, Davies, Thomas, Gallagher, Hayley, Moss, Joe ORCID: https://orcid.org/0000-0002-1866-9752, Faizah, Jaffar and Al-Ahmadi, Wajdan
2016.
Nutraceuticals as preventative and therapeutic agents in atherosclerosis.
Journal of Clinical and Experimental Cardiology
7
(6)
, p. 31.
10.4172/2155-9880.C1.029
|
|
|



Up a level